Global Biochips Market Segments, Analysis, Outlook, Growth 2021 By Acute Market Reports


Acute Market has announced the addition of “Global Biochips Market Analysis And Segment Forecasts To 2021” Market Research report to their Database.

The global market for Biochips is expected to grow at an annual growth rate (CAGR) of approximately 18% (2015-2021). A Biochip is a collection of miniaturized test sites (microarrays) arranged on a solid substrate that can perform hundreds or thousands of simultaneous biochemical reactions in order to achieve higher throughput and speed. Biochips help researchers to quickly see large number of biological analytics and are used in a range of research applications within the biotechnology sector, including pharmaceuticals, proteomics and genomics. Biochips are also used in analysis of organic molecules associated with living organisms and help in identifying gene sequences, airborne toxins, environmental pollutants and other biochemical constituents. Although, biochips have been developed and commercialized in mid eighties but the market has transformed in the starting of last decade

Browse full report with TOC @

Presently, the biochips market is undergoing rapid expansion with the discovery of new applications and the development of existing technologies. The key driving forces for the market of biochips are: growth in personalized medicine market, increase in government spending/ private investment in healthcare budgets and R&D respectively, rising case of lifestyle related diseases and so on. Various factors such as less accuracy of biochips that may lead to wrong analysis, low rate of translation of discoveries in drugs, medical devices and protein biomarkers, low acceptance due to high cost and availability of alternative technologies are restraining the growth of biochips market.

The key players in global biochips market are Agilent technologies Affymetric Inc, Gene system Inc, Agendia BV Inc, Customarray inc, Digital genomics inc, Bio chain institute Inc, Biomerieux SA , Bio-rad laboratories inc, Cepheid Inc, Caliper life sciences Inc, Cybrdi Inc, EMD Millipore, Elim Biopharmaceuticals, Falcon Genomics, Genalyte and so on.

View all reports of this category @

Companies profiled in this report
1 Agilent technologies
2 Affymetrix inc
3 Gene system inc
4 Agendia BV inc
5 Customarray inc
6 Digital genomics inc
7 Bio chain institute Inc
8 Biomerieux SA
9 Bio-rad laboratories inc
10 Cepheid Inc
11 Caliper life sciences inc
12 Cybrdi inc
13 EMD Millipore
14 Elim Biopharmaceuticals
15 Falcon Genomics
16 Genalyte
17 Oxford gene technology
18 Wafergen biosystems inc
19 Predictive biosciences
20 Fluidigm corp
21 Gamida for life group
22 Illumina Inc
23 Life technologies corp
24 Origene technologies Inc
25 Perkinelmer inc
26 Roche nimblegen inc
27 Sequenom
28 Sigma aldrich corp
29 Imgenex
30 ISU ABXIS co ltd
31 Quantalife inc

Blog url:

This Occams Research Report covers
1. Historical data
2. Revenue forecasts, growth rates and CAGR upto 2021
3. Industry Analysis
4. Competitive Analysis
5. Key geographic growth data
6. In-depth profiling of companies

About Acute Market Reports

Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements. Acute Market Reports provide online reports from over 100 best publishers and upgrade Acute Market Reports collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends. Acute Market Reports database consists of 200,000+ market research reports with detailed & minute market research.

For More Information Click Here – Acute Market Reports


Chris Paul

Office No 01, 1st Floor,

Aditi Mall, Baner, Pune,

MH, 411045 India

Phone (India): +91 7755981103

Toll Free (US/Canada):  +1-855-455-8662